194 related articles for article (PubMed ID: 10713707)
1. Low frequency of alterations of the alpha (PPP2R1A) and beta (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms.
Calin GA; di Iasio MG; Caprini E; Vorechovsky I; Natali PG; Sozzi G; Croce CM; Barbanti-Brodano G; Russo G; Negrini M
Oncogene; 2000 Feb; 19(9):1191-5. PubMed ID: 10713707
[TBL] [Abstract][Full Text] [Related]
2. Absence of PPP2R1A mutations in Wilms tumor.
Ruteshouser EC; Ashworth LK; Huff V
Oncogene; 2001 Apr; 20(16):2050-4. PubMed ID: 11360189
[TBL] [Abstract][Full Text] [Related]
3. PPP2R1B gene alterations inhibit interaction of PP2A-Abeta and PP2A-C proteins in colorectal cancers.
Tamaki M; Goi T; Hirono Y; Katayama K; Yamaguchi A
Oncol Rep; 2004 Mar; 11(3):655-9. PubMed ID: 14767517
[TBL] [Abstract][Full Text] [Related]
4. The glycine 90 to aspartate alteration in the Abeta subunit of PP2A (PPP2R1B) associates with breast cancer and causes a deficit in protein function.
Esplin ED; Ramos P; Martinez B; Tomlinson GE; Mumby MC; Evans GA
Genes Chromosomes Cancer; 2006 Feb; 45(2):182-90. PubMed ID: 16276521
[TBL] [Abstract][Full Text] [Related]
5. Alterations in protein phosphatase 2A subunit interaction in human carcinomas of the lung and colon with mutations in the A beta subunit gene.
Ruediger R; Pham HT; Walter G
Oncogene; 2001 Apr; 20(15):1892-9. PubMed ID: 11313937
[TBL] [Abstract][Full Text] [Related]
6. Alterations of the PPP2R1B gene in human lung and colon cancer.
Wang SS; Esplin ED; Li JL; Huang L; Gazdar A; Minna J; Evans GA
Science; 1998 Oct; 282(5387):284-7. PubMed ID: 9765152
[TBL] [Abstract][Full Text] [Related]
7. A high-resolution integrated map spanning the SDHD gene at 11q23: a 1.1-Mb BAC contig, a partial transcript map and 15 new repeat polymorphisms in a tumour-suppressor region.
Baysal BE; Willett-Brozick JE; Taschner PE; Dauwerse JG; Devilee P; Devlin B
Eur J Hum Genet; 2001 Feb; 9(2):121-9. PubMed ID: 11313745
[TBL] [Abstract][Full Text] [Related]
8. Infrequent mutations of the PPP2R1A and PPP2R1B genes in patients with ovarian cancer.
Wang F; Zou Y; Liu FY; Yu XH; Huang H; Zhang N; Qi YY; Liu RF; Liu XY; Chen J; Huang OP; He M
Mol Med Rep; 2013 Jun; 7(6):1826-30. PubMed ID: 23588898
[TBL] [Abstract][Full Text] [Related]
9. Somatic mutations and genetic polymorphisms of the PPP1R3 gene in patients with several types of cancers.
Takakura S; Kohno T; Shimizu K; Ohwada S; Okamoto A; Yokota J
Oncogene; 2000 Feb; 19(6):836-40. PubMed ID: 10698503
[TBL] [Abstract][Full Text] [Related]
10. Genetic and epigenetic screening for gene alterations of the chromatin-remodeling factor, SMARCA4/BRG1, in lung tumors.
Medina PP; Carretero J; Fraga MF; Esteller M; Sidransky D; Sanchez-Cespedes M
Genes Chromosomes Cancer; 2004 Oct; 41(2):170-7. PubMed ID: 15287030
[TBL] [Abstract][Full Text] [Related]
11. Mutations and deletions of the CBP gene in human lung cancer.
Kishimoto M; Kohno T; Okudela K; Otsuka A; Sasaki H; Tanabe C; Sakiyama T; Hirama C; Kitabayashi I; Minna JD; Takenoshita S; Yokota J
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):512-9. PubMed ID: 15701835
[TBL] [Abstract][Full Text] [Related]
12. Subtype-specific mutation of PPP2R1A in endometrial and ovarian carcinomas.
McConechy MK; Anglesio MS; Kalloger SE; Yang W; Senz J; Chow C; Heravi-Moussavi A; Morin GB; Mes-Masson AM; ; Carey MS; McAlpine JN; Kwon JS; Prentice LM; Boyd N; Shah SP; Gilks CB; Huntsman DG
J Pathol; 2011 Apr; 223(5):567-73. PubMed ID: 21381030
[TBL] [Abstract][Full Text] [Related]
13. Infrequent mutations of the activating transcription factor-2 gene in human lung cancer, neuroblastoma and breast cancer.
Woo IS; Kohno T; Inoue K; Ishii S; Yokota J
Int J Oncol; 2002 Mar; 20(3):527-31. PubMed ID: 11836564
[TBL] [Abstract][Full Text] [Related]
14. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
[TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of caspase-14 gene in common carcinomas.
Yoo NJ; Soung YH; Lee SH; Jeong EG; Lee SH
Pathology; 2007 Jun; 39(3):330-3. PubMed ID: 17558860
[TBL] [Abstract][Full Text] [Related]
16. Activating BRAF and N-Ras mutations in sporadic primary melanomas: an inverse association with allelic loss on chromosome 9.
Kumar R; Angelini S; Hemminki K
Oncogene; 2003 Dec; 22(58):9217-24. PubMed ID: 14681681
[TBL] [Abstract][Full Text] [Related]
17. Expression of thyroid hormone receptor/erbA genes is altered in human breast cancer.
Silva JM; Domínguez G; González-Sancho JM; García JM; Silva J; García-Andrade C; Navarro A; Muñoz A; Bonilla F
Oncogene; 2002 Jun; 21(27):4307-16. PubMed ID: 12082618
[TBL] [Abstract][Full Text] [Related]
18. EGFR sequence variations and real-time quantitative polymerase chain reaction analysis of gene dosage in brain metastases of solid tumors.
Franco-Hernandez C; Martinez-Glez V; Arjona D; de Campos JM; Isla A; Gutierrez M; Vaquero J; Rey JA
Cancer Genet Cytogenet; 2007 Feb; 173(1):63-7. PubMed ID: 17284372
[TBL] [Abstract][Full Text] [Related]
19. Alterations of the PPP2R1B gene located at 11q23 in human colorectal cancers.
Takagi Y; Futamura M; Yamaguchi K; Aoki S; Takahashi T; Saji S
Gut; 2000 Aug; 47(2):268-71. PubMed ID: 10896920
[TBL] [Abstract][Full Text] [Related]
20. Expression of full-length p53 and its isoform Deltap53 in breast carcinomas in relation to mutation status and clinical parameters.
Baumbusch LO; Myhre S; Langerød A; Bergamaschi A; Geisler SB; Lønning PE; Deppert W; Dornreiter I; Børresen-Dale AL
Mol Cancer; 2006 Oct; 5():47. PubMed ID: 17054774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
